Appointments

4Basebio PLC
Position: CEO
Holding Balance: 1,242,153 (10.0800%)
Appointed in 2020

Deals on 25 February 2021

DeclaredDealtTypeEPICCompanyDirectorPosSharesPriceValueCur. price% GainGain
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00

All Deals

DeclaredDealtTypeEPICCompanyDirectorPosSharesPriceValueCur. price% GainGain
01/07/2101/07/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,500£4.67£7,005709.60p51.95£3,639.00
01/07/2101/07/21BUY4BB4Basebio PLCHeikki LanckrietCEO650£4.67£3,036709.60p51.95£1,576.40
01/07/2101/07/21BUY4BB4Basebio PLCHeikki LanckrietCEO650£4.67£3,036709.60p51.95£1,576.40
01/07/2101/07/21BUY4BB4Basebio PLCHeikki LanckrietCEO650£4.67£3,036709.60p51.95£1,576.40
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00
26/02/2125/02/21BUY4BB4Basebio PLCHeikki LanckrietCEO1,000£3.45£3,450709.60p105.68£3,646.00
Showing 1 to 7 of 7

Transaction types:

  • BUY - Buy
  • SELL - Sell
  • EXR - Exercise
  • SEXR - Sale Post-Exercise
  • DRI - Dividend Reinvestment
  • DRIP - Dividend Reinvestment Plan
  • AWD - Award
  • TIN - Transfer In
  • TOUT - Transfer Out
  • LOF - In Lieu of Fees/Salary
  • SI - Scrip Issue
  • PLAC - Placing
  • RIS - Rights Issue

Director positions:

  • CEO - Chief Executive Officer
  • CH - Chairman
  • MD - Managing Director
  • FD - Financial Director
  • NED - Non Executive Director
  • ED - Executive Director
  • RES - Resigned
  • D - Director / Unknown